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Reversible  Cerebral  Vasoconstriction  Syndrome  (RCVS)  is  a not  very  well  known  clinical-imaging  entity;  it
is characterized  by  thunderclap  headache,  which  mimics  an  aneurysmal  subarachnoid  haemorrhage,  and
a diffuse  and  segmental  constriction  of  cerebral  arteries,  that  resolves  spontaneously  within  3 months.
The  pathophysiology  remains  unknown.  The  female  gender  is  the  more  affected  and  more  than  half  ofeywords:
eversible Cerebral Vasoconstriction
yndrome
hunderclap headache
emale
cases  occur  in  the  puerperium  or after  exposure  to  vasoactive  substances.  Typically,  RCVS is self-limited
and  has a benign  course,  although  it  may  have  more  serious  complications  with  permanent  neurologic
sequelae  and  death.  Treatment  is predominantly  supportive  and  directed  to the  symptoms.
©  2016  PBJ-Associac¸a˜o  Porto  Biomedical/Porto  Biomedical  Society.  Published  by  Elsevier  Espan˜a,
en  acomplications S.L.U.  This  is an  op
ntroduction
Reversible Cerebral Vasoconstriction Syndrome (RCVS) is a cere-
rovascular disease characterized by severe headache, mimicking
neurysmal subarachnoid haemorrhage,1 with or without other
cute neurologic symptoms, and noninﬂammatory, nonatheroscle-
otic diffuse segmental constriction of cerebral arteries, which
esolves spontaneously within 3 months.2 For nearly 30 years, it
as been described in several clinical settings, with other names,
uch as post-partum angiopathy,3 Call syndrome,4 central nervous
ystem (CNS) pseudovasculitis,5 benign angiopathy of the CNS.6,7
In 2007, Calabrese et al. proposed the term RCVS, unifying all
f these angiopathies with similar clinical course and angiographic
haracteristics, and a set of diagnostic criteria.8 In the following
ears, the publication of two large prospective cohorts9–14 and one
arge retrospective series,15 provided a better recognition of this
yndrome.
RCVS is clinically important as it occurs in various clinical set-
ings, in young people, especially females, in which the differential
iagnosis with other more serious entities is urgent because it
mplies different attitudes and therapeutic strategies. It typically
as a benign course but serious complications arise in more than
0% of patients, particularly ischaemic and haemorrhagic strokes,
nd even death.
The aim of this study was to perform a narrative review of RCVS
n order to alert the medical community about the importance of
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early diagnosis and proper treatment of the most serious compli-
cations of this disease and the need for research to clarify in an
objective manner the pathophysiology and therapeutic orientation.
Methods
We searched PubMed using the term “reversible cerebral vaso-
constriction syndrome”  and we  selected review articles from
01/01/2010 to 31/01/2015; the list of bibliographic references of the
review articles considered were also screened, totalling 81 articles.
Deﬁnition
RCVS is characterized by recurrent acute severe headaches
which may  be associated with seizures and focal neurological
deﬁcits. There is no speciﬁc laboratory investigation and cere-
brospinal ﬂuid (CSF) analysis is normal in most cases. Cerebral
angiography shows alternating segmental constrictions and dila-
tions. However, computed tomography (CT), magnetic resonance
imaging (MRI) and angiography may  be normal until the ﬁrst week
of evolution of the disease. It is a self-limited entity, with headache
resolution and subsequent disappearance of arterial changes from
1 to 3 months after the onset of symptoms. Meanwhile, severe
complications can occur with permanent neurological damage and
death.
A set of diagnostic criteria is not universally accepted; how-
ever those proposed by Calabrese et al. (Table 1)8 are the basis for
diagnostic approach.
d by Elsevier Espan˜a, S.L.U. This is an open access article under the CC BY-NC-ND
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Table 1
Diagnostic criteria of the reversible cerebral vasoconstriction syndrome.
Intense, acute headache, with or without additional neurological signs or
symptoms
Catheter, CT, or MRI  angiography demonstrating segmental cerebral artery
vasoconstriction
No  evidence for aneurysmal SAH
Reversibility of angiographic abnormalities within 12 weeks of onset; if
death occurs before the follow-up studies are complete, the autopsy has to
rule  out vasculitis, intracranial atherosclerosis and aneurysmal SAH, which
can also manifest with headache and stroke
CSF analysis normal or close to normal (protein level < 80 mg/dL,
leukocytes < 10/mm3, normal glucose level)
Adapted from Calabrese et al.8
CT, computed tomography; MRI, magnetic resonance imaging; SAH, subarachnoid
h
C
a
s
cases, respectively.2,11,13–15
T
S
A
B
eaemorrhage; CSF, cerebrospinal ﬂuid.
linical presentation
Despite the aetiological heterogeneity, clinical manifestations
re similar.
RCVS has a typical acute and self-limited course without new
ymptoms after 1 month.2,13
able 2
ummary of the three main series of reversible cerebral vasoconstriction syndrome.
Author Chen et al. 
Country Taiwan 
Type  of study
Prospective 
Monocentric 
Year(s) of publication 2006, 2008, 2010 
References 9–12 
Observation period 2002–09 
Number of cases 77 
Average age (range) 47.7 (10–76) 
Proportion of women (%) 89 
Comorbidities
History of migraine (%) 17 
History of hypertension (%) 25 
Precipitating factor
Any precipitating factor (%) 8 
Postpartum (%) 1 
Vasoactive drugs (%) 3 
Headache
Headache at onset (%) 100 
Recurrent thunderclap (%) 100 
Focal neurological deﬁcit
Transient deﬁcit (%) 8 
Permanent deﬁcit (%) 2.5 
Seizures (%) 1 
BP  (SBP# > 160 and/or DBP# > 90 mmHg) (%) 46 
Image
Initial CT or MRI  normal (%) 
Any  abnormal CT or MRI  (%) 12 
Convexity SAH (%) 0c
ICH  (%) 0c
Cerebral infarction (%) 8 
PRES (%) 9 
CSF  analysis (%) 18 
Protein > 60 mg/dL (%) 0 
White blood cells 5–10/#mL (%) 
White blood cells > 10/#mL (%) 0 
Death (%) 0 
Recurrences (%) 8 
Long-term sequelae (%) 3 
dapted from Ducros2 and Néel et al.37
P, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; SAH, suba
ncephalopathy syndrome; CSF, cerebrospinal ﬂuid.
a 40% of patients had a history of headaches.
b No speciﬁc data were reported.
c Haemorrhage was an exclusion criterion in this series.med. J. 2016;1(2):65–71
The main symptom in 95–100% of cases is headache2 and it can
be the only symptom8,13,16–19 (Table 2). It is typically a thunder-
clap headache (TH) which reaches maximum intensity in seconds,
mimicking the onset of an aneurysm ruptured headache. On aver-
age, it lasts 3 h,20 and repeats four times over a period of 1–4
weeks,2,9,10,13 often triggered by sexual activity, stress, Valsalva
manoeuvre and/or emotions. The typical headache is bilateral,
although it may  be unilateral, starting in the occipital region,
followed by diffuse pain,2 and often accompanied by nausea, vom-
iting, photophobia and phonophobia. In some cases, the headache
does not correspond to the deﬁnition of TH, being less intense
or more progressive; the presentation of other symptoms with-
out the headache is exceptional.2 If accompanied by neck pain, it
is especially necessary to exclude cervical artery dissection.12,13,21
Although patients may  have migraine as a comorbidity, they report
the TH of RCVS as having location, degree and quality different from
their usual headache.20,22 This entity may  also be associated with
focal neurological deﬁcits, transient or permanent, and seizures, as
reported in three major series (Table 2), in 8–43% and 1–17% ofThe seizures can be at the onset; their recurrence is rare.2,3,22–24
Transient focal deﬁcits are present in little more than 10% of
patients, last 1 min  to 4 h, they are often visual, but can also be
Ducros et al. Singhal et al.
France United States of America
Prospective Retrospective
Monocentric Multicentric
2007, 2010 2011
13,14 15
2004–08 1993–2009
89 139
43.2 (19–70) 42.5 (13–69)
69 81
27 a
11
62
13 11
52 42
100 95
91 78
16 43
11
4 17
34 Someb
80 55
37 81
30 34
12 20
6 39
8 38
88 82
12 16
17 12
8 3
0 2
0
6 20
rachnoid haemorrhage; ICH, intracerebral haemorrhage; PRES, posterior reversible
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otor, sensory or dysphasic.2 The majority have sudden onset and
re similar to a transient ischaemic attack (TIA), though they can
imic  positive symptoms of a migraine aura.2,13
Neurological deﬁcits exceeding 12 h are not likely to improve.
ermanent deﬁcits suggest a stroke and include hemiplegia, apha-
ia, hemianopia or cortical blindness.2,7,14,15,23 Cerebellar strokes
ay  also occur.
In more than a third of patients, hypertensive peaks (systolic
lood pressure > 160 mm Hg) occur during headache crisis.11,13,23
t is not clear whether this is due to the pain, a response to the
asoconstriction of arteries, or integrates the manifestations of the
isease.
isk/susceptibility factors and complications
Female gender appears to be a risk factor in the development of
CVS,25 which is also more severe in women than in men.13,14
Physiological changes during pregnancy and the postpartum
eriod appear to increase susceptibility to develop this disease,25
s well as hormonal therapy,26 pharmaceutical vasoconstrictors,
ncluding those used in the treatment of migraine,27 which is more
ommon in women, and the use of recreational drugs25; genetic
actors appear to be the basis of individual susceptibility or can
ffect severity and clinical course.12,26
More than 90% of patients have a good prognosis.25 How-
ver, 10% of patients have severe complications15 that can lead to
eath. Complications include cerebral infarction (4–40%), intrac-
rebral haemorrhage (ICH) (6–20%), subarachnoid haemorrhage
SAH) (22–34%) and posterior reversible encephalopathy syndrome
PRES) (less than 10%).9,13,15,25 These values of incidence reported
ay  be the result of bias in recruitment of participants (perhaps
ith the most symptomatic patients seeking medical help) selec-
ion criteria, and the context of each patient.2,16 For example, the
ases of ischaemic stroke and ICH in patients who developed post-
artum RCVS described by Fugate et al. appear to be greater than
hose described in Ducros et al.16,28,29
Haemorrhagic complications (parenchymal and SAH), PRES and
eizures often occur in the ﬁrst week of the disease.10,13,16,30,31 In
ontrast, ischaemic events and resulting focal neurological deﬁcits
ccur later, with a peak between the ﬁrst and second week of RCVS
nset. Brain ischaemia can occur even later in the course of the
yndrome, occasionally after the resolution of symptoms such as
eadache, reﬂecting the well documented apparent delay in resolv-
ng cerebral vasoconstriction.11,16
The female gender and a history of migraine are independent
isk factors for haemorrhagic complications.14 On the contrary, a
istory of hypertension and peaks of elevation in systolic blood
ressure are not associated with the risk of haemorrhage.14 The
dentiﬁcation of migraine, mainly with aura, as a risk factor for
aemorrhagic complications, is particularly relevant, since previ-
us studies have not highlighted migraine as a risk factor for global
CVS.9,13,14 More studies are needed to re-evaluate migraine as
 risk factor for RCVS haemorrhagic complications, for RCVS, or
oth.14
etiology
RCVS can occur spontaneously, without apparent cause, or
e secondary to endogenous or exogenous precipitating factors
Table 3).
There are differences in the results presented by the series
Table 2). In Chen et al., 96% of cases of RCVS were idiopathic,
n contrast to the 37% in Ducros et al. In the Ducros’ series,13,14
he use of vasoactive drugs contributed to most cases of RCVS
52%), with postpartum being the second most common causemed. J. 2016;1(2):65–71 67
with 13% of cases. With respect to drugs, cannabis was  the most
recorded, particularly in males. Despite being the most commonly
consumed illicit drug,32 it had until now been rarely implicated in
this syndrome.20,33 Other vasoactive drugs are pointed to, espe-
cially in females, namely selective serotonin reuptake inhibitors
and nasal vasoconstrictors.
Ducros et al.13 suggests two  new precipitating factors: binge-
drinking, at least in combination with vasoactive substances, which
is already considered a risk factor for stroke and a precipitating
factor previously associated with RCVS,34 and the use of interferon
alpha, previously implicated in a case of multiple brain infarcts35
and in another one with PRES,36 though both without documented
cerebral vasoconstriction. Ducros et al.13 even underlines the need
for a case–control study to assess the strength of the association
between these risk factors and RCVS.
The results obtained by Singhal et al.15 corroborate those
obtained by Ducros et al.13 Other potential precipitating factors
have been mentioned in literature, especially in isolated obser-
vations, and some raise doubts about the nosological boundaries
between RCVS and PRES.37,38
The epidemiological differences in the Western and Taiwanese
series can be due to bias in the recruitment of participants or to the
consumption of illicit substances.37
Time latency may  vary between exposure to a precipitating fac-
tor and the development of RCVS, which can be a few days to several
months.17 This ﬁnding and the ubiquity of precipitating factors may
be a result of chance in part of these associations.8,16,17,28,39–51
In spontaneous cases, there may  be a genetic predisposition or
there might be some unknown aetiologies that make individuals
particularly susceptible.16
Pathophysiology
The pathophysiology of this syndrome remains an enigma, it
seems to be a multifactorial process.
The dysfunction of the vascular tone regulation appears to be
the central element in the pathophysiology.8,13,17,19,25,52 A rapid
change of vascular tone can lead to vasoconstriction and vasodi-
latation of segmental small vessels and the sudden stretching
of arterial walls can cause the TH in the initial phase.14,26 This
appears to be induced by sympathetic stimulation, endothelial dys-
function and oxidative stress.34–36,49,50 The association of RCVS
with outbreaks of hypertension, vasoactive substance intake and
phaeochromocytoma support the role of sympathetic stimula-
tion. On the other hand, the overlap with PRES supports the role
of endothelial dysfunction. Some hormones and biochemical fac-
tors have been involved in vascular tone dysregulation, namely
endothelin-1, oestrogen, serotonin, nitric oxide and prostaglandins.
For example, levels of 8-iso-prostaglandin F2alfa, a marker of oxida-
tive stress and a potent vasoconstrictor, seem to be related to the
severity of the syndrome, thus supporting the role of oxidative
stress. Other factors, including the placental growth factor, soluble
placental growth factor receptor and soluble endoglin, play a role
in angiogenesis and have been implicated in postpartum RCVS.31,52
Genetic factors may  be the basis of individual susceptibility to
develop RCVS and in the severity of its clinical course.52 Recently,
the Brain-derived neurotrophic factor gene (BDNF) polymorphism
(Val66Met), which is important for neuronal survival, neurogenesis
and synaptic plasticity, has been associated with severe vasocon-
striction in patients with RCVS.12,52
EpidemiologyRCVS occurs in all age groups, including paediatric
patients.11,53,54 The peak occurrence is at 42 years of age, though a
decade earlier in men13,19,20 and is more common in women.
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Table 3
Potential aetiologies and associated conditions of RCVS.
General categories Speciﬁc entities
Primary (idiopathic) Primary headaches (thunderclap headache, sexual activity, exercise)
Secondary
Pregnancy Postpartum, pre-eclampsia, eclampsia
Vasoactive substances Recreational drugs: cannabis, cocaine, LSD, amphetamines, ecstasy, binge-drinking
Ergots: ergotamine tartrate, bromocriptine, methylergometrine, lisuride, methergine
Sympathomimetics: ephedrine, pseudoephedrine, phenylpropanolamine, isometheptene, diet pills
Serotonergic drugs: SSRI, triptans
Immunosuppressants: tacrolimus (FK-506), cyclophosphamide, Interferon alfa
Others: ginseng, liquorice, nicotine patches, indomethacin, oral contraceptive pills, hormonal ovarian
stimulation for intrauterine insemination
Catecholamine secreting tumours Pheochromocytoma, glomus tumours, bronchial carcinoid tumour
Extra- or intra-cranial arterial disorders or procedures Cervical artery dissection, aortic dissection, unruptured intracranial aneurysm, ﬁbromuscular dysplasia,
post carotid endarterectomy
Blood products Erythropoietin, intravenous immunoglobulin, massive blood transfusion
Intracranial disorders or surgery CSF hypotension, intracranial haemorrhage, spinal subdural haematoma, neurosurgery, head trauma
Miscellaneous Systemic lupus erythematosus, Hypercalcemia, porphyria, microangiopathic haemolytic anaemia,
autonomic dysreﬂexia, ascent to high altitudes
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SD, lysergic acid diethylamide; SSRI, selective serotonin reuptake inhibitors.
Incidence is unknown, although the syndrome does not appear
o be rare, considering cases reported in retrospective and prospec-
ive studies.2 Recent work even suggest a possible increase in
ncidence; however it remains unclear if this is due to a real increase
n new cases or whether it is a consequence of the improvement of
maging techniques and awareness of the disease.52,55 Neverthe-
ess, RCVS probably remains misdiagnosed and should be included
n the list of differential diagnoses in younger patients with crypto-
enic stroke or intense headache.16,56 Cases have been reported in
ll continents and the three great series from Asia, Europe and North
merica have documented various forms of presentation, from the
ost common, benign, to the rarest, deadly2 (Table 2). Despite the
ifferences observed between sets, it is not possible to say whether
his is due to ethnic differences or differences in the recruitment
riteria of the participants.2
iagnosis
As TH is the main symptom, it is necessary to explore it thor-
ughly, since there are other diseases that present with TH as well,
lthough with some particularities as will be discussed.
Considering the algorithm (Fig. 1) and the proposed diagnos-
ic criteria by Calabrese et al., a good clinical history is needed,
ith characterization of the headache, past medical history, usual
edication, comorbidities and a complete physical examination, to
iscard the presence of meningeal signs and fever, to evaluate the
evel of awareness and the presence of focal neurological deﬁcits.
fter exclusion of the most common pathologies by neuroimag-
ng and study of the CSF, additional studies are necessary for the
haracterization of the cerebral vasculature. The complete blood
ount and biochemistry are generally normal. Exclusion of vasculi-
is and vasoactive tumours (carcinoid and pheochromocytoma) is
seful. Additionally, it is important to screen serum and urine for
asoactive drugs.
The diagnosis is based on angiographic exams and requires
he initial demonstration of diffuse segmental vasoconstriction of
erebral arteries, as well as its reversibility (complete or marked
ormalization of arteries) in 12 weeks after onset of the disease.8
Initially, 55–80% of patients have a normal CT or MRI  (Table 2).
owever, in subsequent images, 12–81% of patients have changes
onsistent with SAH, convexity ICH, cerebral infarction and PRES.
aemorrhagic complications are the most frequent.
Particular attention must be payed to the ICH, which seems to
e more common in women and people with migraine.14 It occursearly in the course of RCVS, revealing itself in most cases by a TH
with a persistent focal deﬁcit. Attention is also important to PRES,
due to clinical and imaging overlapping with RCVS and the possi-
bility of simultaneous occurrence.3,38,57,58 More than 85% patients
with PRES demonstrate cerebral vasoconstriction similar to RCVS in
conventional angiography. Reversible cerebral oedema alike PRES
may  also occur in 9–38% of patients with RCVS.2,16
Regarding imaging, catheter cerebral angiography is the gold
standard diagnostic exam. It allows a real-time assessment of the
calibre and ﬂow of vessels, provides a good view of the small and
peripheral vessels, with good spatial and temporal resolution, and
allows for acting therapeutically with intra-arterial vasodilators. It
has the disadvantage of being an invasive method, with potential
vascular damage and stroke,59 and it is impractical for follow-up.
In one of the series by Ducros et al.13, over 9% of patients suffered
transient neurologic deﬁcits after cerebral angiography.13 This type
of angiography should be reserved for cases whose diagnoses raise
additional questions.26
CT and MRI  angiographies (CTA and MRA) allow vascular diag-
nosis, with the advantage of not being intrusive.
CTA overcomes the limitations of conventional angiography,
allowing a good assessment of vasoconstriction in patients with
RCVS.9 It has been singled out as a speciﬁc and very sensitive tool
in the assessment of intracranial vasculature,60 however it is not
feasible for sequential follow-up due to exposure to radiation and
contrast.
Chen et al. demonstrated that the assessment with MRA is
valid.11 Transcranial Doppler (TCD) imaging has long been used and
validated in the study of intracranial vessel spasm,59–61 allowing
sequential monitoring. It is a non-invasive method, innocuous, with
high reproducibility, which makes it possible to evaluate the vessel
vasoconstriction and monitor haemodynamic changes in patients
with RCVS. According to a study, cerebral vasoconstriction indica-
tors, including high mean ﬂow velocity of the middle cerebral artery
(>120 cm/s) and a high hemispheric index (>3), were associated
with an increased risk of developing PRES or ischaemic stroke.10,16
However, the acceleration of the velocity in arteries at the base of
the skull do not often reach these values in RCVS as in aneurys-
mal  SAH and the focal character and the temporal evolution of
the ﬂow velocities should be valued in this case. The TCD has the
disadvantage of not allowing the evaluation of small vessels.56
It is necessary to keep in mind that the arterial vasoconstriction
may  not be evident in the ﬁrst angiographic study; in cases with
high clinical suspicion, the repetition of these exams is indicated.62
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Headache                                                                                                Level of consciousness
Age                                                                                                      Focal neurological deficit s
Sex                                                                                                                                     Fever
Drugs                                                                                                                          Meningism
Comorbidities                                            
                            SAH
                       PACNS
Cerebral venous thrombosis
 Carotid or vertebral artery dissection
 CNS infection
  Space occupying lesion
       CSF hypotension (MRI)
Pituitary apoplexy (MRI)
Treat SAH                                                           
PACNS                                       Normal  
CNS infection  
CSF hypotension                       
If headache persists,
recurs or history 
suggesting RVCS,
use of neuroimaging  
CTA
MRA
CA
TCD
Thunderclap headache/acute, severe 
Physical exam Clinical history
CT/ CTA or MRI/MRA
Normal 
Abnormal
LP with manometryAbnormal
F RI, ma
a ranial
A
A
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w
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uig. 1. An algorithm for RCVS diagnosis. CTA, computed tomography angiography; M
ngiitis  of the central nervous system (CNS); CA, catheter angiography; TCD, transc
dapted from Tan et al.56
s suggested by Ducros et al.,13 the segmental vasomotor dysregu-
ation seems to start in the most peripheral arterioles, progressing
entripetally to the medium and large calibre cerebral arteries,
hich are viewed more easily.52,63 This centripetal progression
an explain the time lag between headaches and vasoconstriction,
iven that headaches appear before any detectable vasoconstric-
ion and this extends on average 14 days after headache resolution.
herefore, headache may  be due to the involvement of small distal
rteries, whose rapid changes of calibre (constriction or dilation)
timulate perivascular pain-sensitive ﬁbres.13
In imagining, the main differential diagnosis, after aneurys-
al  HSA is ruled out, is CNS vasculitis (primary angiitis of the
NS, PACNS).26,64 This distinction is important, though difﬁcult,
ecause the treatment is quite different.7,8,17,52 The resolution of
he cerebral vasoconstriction in the mid-term angiographic con-
rol allows for the differentiation between these two entities. In
ddition, advanced techniques of MRI  that evaluate the arterial
all can help the differential diagnosis at an early stage of the
isease, because there are abnormal captures of the contrast prod-
ct on the wall of the involved arteries in PACNS.62 Additionally,gnetic resonance imaging; MRA, magnetic resonance angiography; PACNS, primary
 Doppler.
the headache of the vasculitis has an insidious onset, progressing
gradually, and thus distinct from that typical of RCVS,7,8,17,30,65,66
and it is more common in older men, unlike RCVS that is typical
in young/middle aged women.52,65,67 There are also differences in
the CSF analysis because, unlike RCVS, in vasculitis it is not normal,
with proteins and leucocyte counts increase with values gener-
ally >100 mg/dL and 5–10 cells/mm3, respectively.8,15,17,30,40,52,65
Finally, patients with vasculitis have a fulminant course, with
poor prognosis, particularly if treatment with immunosuppressant
steroids and cytotoxic agents is delayed; however, lack of these
drugs beneﬁts RCVS.17,52,65,67
Another differential diagnosis to be noted is cervical artery dis-
section, as it evolves with headache/neck pain and can even be
associated with RCVS.20
TreatmentThere is no established treatment for RCVS25 and there is
no form of treatment which clearly modiﬁes the natural his-
tory of vasoconstriction.3 The therapeutic approach is based on
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bservational studies and the experience of the doctor. However,
he timely recognition of the syndrome is important. All patients
ith suggestive clinical history, no evidence of another cause for
he symptoms, and initial normal angiograms, should be consid-
red as having possible or likely RCVS and thus receive the same
ymptomatic treatment as patients with proven vasoconstriction.2
All patients need symptomatic treatment, which includes the
iscontinuation of any vasoactive drug2,6,15,20 and the suspension
f Valsalva manoeuvres or other headache precipitating factors for
 few days to weeks, depending on the severity of the headache.
Treatment includes analgesics, antiepileptic drugs for seizures,
lood pressure monitoring and admission to the intensive care unit
n severe cases.2
Drugs targeting the vessel spasm should be considered when
erebral vasoconstriction is documented. Vasodilators, including
alcium channel blockers with systemic action, by reducing systolic
lood pressure, can compromise the cerebral perfusion in patients
ith severe vasoconstriction, and should therefore be used with
aution. Nimodipine is the most used and may  have a more elec-
ive action on cerebral circulation. Despite reducing the number of
pisodes and the intensity of the headache, prospective and retro-
pective studies suggest that it does not affect the time course of
erebral vasoconstriction. It may  be given orally or intravenously
t a dose used for prevention of vessel spasm in aneurysmal SAH.
he duration of treatment should range from 4 to 12 weeks.2 New
leeding, TIA and stroke are reported in some patients, even if
reated for several days.2,13,68 Other drugs include nicardipine,54
erapamil15 and magnesium sulphate (in the treatment of post-
artum angiopathy).69
In the most severe cases, milrinone, nimodipine and
poprostenol administered intra-arterially, and balloon angio-
lasty with variable success have been used.2,29,70 These are
elicate and high risk interventions, and should be restricted to
atients who show clear signs of clinical progression.2,71
Glucocorticoids should be avoided because they are an indepen-
ent predictor of poor prognosis.
rognosis
In most patients, the course of this syndrome is self-limited and
enign. However, complications are frequent and the prognosis
ay  be unfavourable. In the American series, 81% of patients had
rain image compatible with lesion (Table 2). Despite this, the rate
f permanent neurological deﬁcits is very low and deaths are rare.15
he recurrence rate was described as being about 8%.11 Cerebral
nfarct and ICH are predictors of poor prognosis.15
onclusion
RCVS is traditionally considered to have a benign and monopha-
ic clinical course. However, it may  present an unfavourable course
ith rapid progression of blood vessel spasm, or with hemorrhage,
ausing high morbidity, or even have a fatal outcome.
Multicentre retrospective and prospective studies can help to
stablish the true prevalence and incidence of this entity and its
linical presentation, with emphasis on atypical presentations.
The initial suspicion of RCVS should lead to clinical surveil-
ance and intensive imaging, reaching a deﬁnitive diagnosis and
uling out other differential diagnosis, particularly those with spe-
iﬁc treatments. The identiﬁcation of potential precipitating agents,
heir eviction or control is essential.
This review highlights the importance of new research to further
larify the pathophysiology of this syndrome and thus to contribute
o a more speciﬁc and effective therapeutic approach.
3
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